Anticancer Therapies – Products
Product News
Critical Outcome Technologies Inc. Announces Definitive Proof of COTI-2’s Target and Single
COTI-2 is the first drug developed using the Company’s proprietary artificial intelligence system, CHEMSAS®.
Product News
PRECOS Partners with Reliable Cancer Therapies to Provide Rigorous Scientific Evidence for Complementary Cancer Medicines
PRECOS provide drug efficacy work to support RCT's research on complementary medicines.
Product News
Endomagnetics Secures Funding for Expansion and Product Launch
Technology will extend the availability of best practice in cancer staging globally.
Product News
Adaptimmune Announces Opening of Pilot Clinical Trial in Synovial Sarcoma
Personalized therapy is targeted to patients who have failed initial treatment.
Product News
Metanomics Health Launches its Energy Metabolite Platform - a Unique Target Platform Based on Metabolite Profiling
The targeted platform maps key metabolites affecting the energy status of a biological system.
Product News
Plasticell‘s CombiCult™ v2.0 Platform Wins International R&D 100 Award
Plasticell’s high throughput screen for stem cell differentiation joins list of the most significant technology products developed globally in the last 49 years.
Product News
FDA Approves Immunovaccine's Application for a Phase I/II Clinical Trial for an Ovarian Cancer Vaccine
DPX-Survivac will be tested in patients with ovarian cancer.
Product News
OGT to Develop Tumour Profiling Assay to Facilitate Personalized Cancer Treatment
Company receives £1.16m award from the UK’s Technology Strategy Board.
Product News
First Patients are Vaccinated in IMPRINT, immatics’ Pivotal Phase III Trial with IMA901 in Patients with RCC
The trial is designed to demonstrate the overall survival benefit of IMA901 in combination with standard first-line therapy in RCC patients.
Product News
Adaptimmune Announces Opening of Phase I/II Clinical Trial for Metastatic Melanoma at Washington University, St. Louis
Trial could generate future alternative treatment for metastatic melanoma.
Advertisement
